Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 7.47 -1.84% -0.14
KALA closed down 1.84 percent on Friday, April 16, 2021, on 47 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical KALA trend table...

Date Alert Name Type % Chg
Stochastic Reached Overbought Strength 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Crossed Above 20 DMA Bullish -1.84%
Gapped Up Strength -1.84%
Up 3 Days in a Row Strength -1.84%
20 DMA Resistance Bearish 3.61%
Fell Below 20 DMA Bearish 8.73%
Crossed Above 20 DMA Bullish -1.32%
Up 3 Days in a Row Strength -1.32%
Older End-of-Day Signals for KALA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 1 day ago
Fell Below Previous Day's Low 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
Rose Above 20 DMA 3 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Eye Pain Organ Systems Inflammation Ophthalmic Macular Degeneration Related Macular Degeneration Retina Tyrosine Kinase Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Receptor Tyrosine Kinase Blepharitis Post Surgical Ocular Inflammation

Is KALA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.68
52 Week Low 6.0
Average Volume 2,319,554
200-Day Moving Average 8.14
50-Day Moving Average 7.84
20-Day Moving Average 7.22
10-Day Moving Average 7.27
Average True Range 0.49
ADX 13.08
+DI 25.73
-DI 21.75
Chandelier Exit (Long, 3 ATRs ) 6.86
Chandelier Exit (Short, 3 ATRs ) 7.48
Upper Bollinger Band 8.11
Lower Bollinger Band 6.32
Percent B (%b) 0.64
BandWidth 24.77
MACD Line -0.08
MACD Signal Line -0.16
MACD Histogram 0.0797
Fundamentals Value
Market Cap 418.88 Million
Num Shares 56.1 Million
EPS -2.87
Price-to-Earnings (P/E) Ratio -2.61
Price-to-Sales 64.50
Price-to-Book 3.86
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.00
Resistance 3 (R3) 7.99 7.82 7.91
Resistance 2 (R2) 7.82 7.68 7.82 7.88
Resistance 1 (R1) 7.64 7.60 7.56 7.65 7.85
Pivot Point 7.47 7.47 7.42 7.47 7.47
Support 1 (S1) 7.29 7.33 7.21 7.30 7.09
Support 2 (S2) 7.12 7.25 7.12 7.06
Support 3 (S3) 6.94 7.12 7.03
Support 4 (S4) 6.95